Louie Ngar Yee - 22 Dec 2025 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Louie Ngar Yee
Issuer symbol
MAIA
Transactions as of
22 Dec 2025
Net transactions value
+$211,110
Form type
4
Filing time
23 Dec 2025, 08:14:35 UTC
Previous filing
06 Oct 2025
Next filing
05 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Louie Ngar Yee Director 444 WEST LAKE STREET, SUITE 1700, CHICAGO /s/ Louie Ngar Yee 22 Dec 2025 0001913264

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MAIA Common Stock Purchase $100,000 +81,699 +7% $1.22 1,248,888 22 Dec 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Stock Options Purchase $111,111 +81,699 $1.36 81,699 22 Dec 2025 Common Stock 81,699 $1.36 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on December 22, 2025
F2 These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on December 22, 2025. The options are exercisable beginning on the six month anniversary of the issuance date and expire 3-years after the initial issuance date.